» Articles » PMID: 16198223

Adherence Beliefs Among Breast Cancer Patients Taking Tamoxifen

Overview
Publisher Elsevier
Specialties Health Services
Nursing
Date 2005 Oct 4
PMID 16198223
Citations 89
Authors
Affiliations
Soon will be listed here.
Abstract

Information about the reasons for non-adherence among breast cancer patients taking tamoxifen is essential for the development of interventions that may increase adherence. The present study investigated treatment experiences and perceptions among women taking tamoxifen and how these related to adherence behaviour. Hundred and ten women completed questionnaires including the Women's Health Questionnaire, Hot Flushes and Night Sweats Questionnaire, Beliefs about Medicine Questionnaire and a self-report measure of adherence. Non-adherers were more likely to report a belief that there was nothing to be gained from taking tamoxifen whereas adherers were more likely to report that tamoxifen would stop them from developing breast cancer. The main reason for not taking tamoxifen was reported to be side effects. There were no differences between adherers with regard to the strategies used to remember to take tamoxifen or with regard to the time of day tamoxifen was taken. The results have implications for the role of health professionals in informing patients of the purpose of their treatment and for the development of symptom-management interventions for this patient group.

Citing Articles

Impact of Patient Personality on Adherence to Oral Anticancer Medications: An Opportunity?.

Jafari M, Shahverdian A, Sadigh G, Van Etten R JMIR Cancer. 2024; 10:e57199.

PMID: 39475848 PMC: 11561440. DOI: 10.2196/57199.


Active symptom monitoring for premenopausal women with breast cancer initiating adjuvant endocrine therapy: Protocol for the SWOG S2010 randomized controlled efficacy trial.

Henry N, Unger J, Vaidya R, Darke A, Skaar T, Fisch M Contemp Clin Trials. 2024; 147:107712.

PMID: 39395534 PMC: 11620912. DOI: 10.1016/j.cct.2024.107712.


Remote Monitoring App for Endocrine Therapy Adherence Among Patients With Early-Stage Breast Cancer: A Randomized Clinical Trial.

Graetz I, Hu X, Kocak M, Krukowski R, Anderson J, Waters T JAMA Netw Open. 2024; 7(6):e2417873.

PMID: 38935379 PMC: 11211959. DOI: 10.1001/jamanetworkopen.2024.17873.


The lived experience of patients with breast cancer on adjuvant endocrine therapy: side effects and coping strategies during the first year of medication initiation.

Gomaa S, Lopez A, Slamon R, Smith R, Lapitan E, Nightingale G Support Care Cancer. 2023; 31(12):719.

PMID: 38008817 DOI: 10.1007/s00520-023-08170-y.


Optimization of an Information Leaflet to Influence Medication Beliefs in Women With Breast Cancer: A Randomized Factorial Experiment.

Green S, Hall L, French D, Rousseau N, Parbutt C, Walwyn R Ann Behav Med. 2023; 57(11):988-1000.

PMID: 37494669 PMC: 10578395. DOI: 10.1093/abm/kaad037.